ALLMedicine™ Hepatitis Center
Research & Reviews 37,563 results
https://doi.org/10.1177/10732748221103624
Cancer Control : Journal of the Moffitt Cancer Center; Lopez W, Sayles H et. al.
May 21st, 2022 - People living with HIV (PLWH) have an increased risk of lung cancer compared to the general population. In 2013, the United States Preventive Services Task Force (USPSTF) released their lung cancer screening (LCS) guidelines. However, the impact o...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112460
Journal of Hepatocellular Carcinoma; Zhao D, Zhang X et. al.
May 21st, 2022 - The aim of this study was to identify and validate novel biomarkers for distinguishing among hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC), liver fibrosis/liver cirrhosis (LF/LC) and chronic hepatitis B (CHB). Transcriptomic seque...
https://doi.org/10.1111/liv.15313
Liver International : Official Journal of the Internation... Lv Y, Fan D et. al.
May 21st, 2022 - Liver diseases are major causes of illness and death worldwide. In China, liver diseases, primarily viral hepatitis, affect approximately 300 million people, thus having a major impact on the global burden of liver diseases. Portal hypertension is...
https://doi.org/10.1371/journal.pone.0259727
PloS One; Manzoor S, Khalid M et. al.
May 21st, 2022 - Major HCV infections lead to chronic hepatitis, which results in progressive liver disease including fibrosis, cirrhosis and eventually hepatocellular carcinoma (HCC). P2X4 and P2X7 are most widely distributed receptors on hepatocytes. Full length...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110637
Transplant International : Official Journal of the Europe... Doherty DT, Athwal V et. al.
May 21st, 2022 - Background: Donor hepatitis-C (HCV) infection has historically represented a barrier to kidney transplantation (KT). However, direct-acting antiviral (DAA) medications have revolutionised treatment of chronic HCV infection. Recent American studies...
Guidelines 105 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013624
Clinical and Molecular Hepatology;
Apr 18th, 2022 - KASL clinical practice guidelines for management of chronic hepatitis B.|2022| ,|therapeutic use,genetics,drug therapy,
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979596
MMWR. Morbidity and Mortality Weekly Report; Weng MK, Doshani M et. al.
Apr 1st, 2022 - Hepatitis B (HepB) vaccines have demonstrated safety, immunogenicity, and efficacy during the past 4 decades (1,2). However, vaccination coverage among adults has been suboptimal, limiting further reduction in hepatitis B virus (HBV) infections in...
https://doi.org/10.1016/j.clinre.2022.101871
Clinics and Research in Hepatology and Gastroenterology; Duclos-Vallée JC, Debray D et. al.
Feb 3rd, 2022 - Best practice guidelines for France regarding the diagnosis and management of autoimmune hepatitis.|2022|Duclos-Vallée JC,Debray D,De Martin E,Beux EL,Louvet A,|
https://doi.org/10.1016/j.clinre.2021.101773
Clinics and Research in Hepatology and Gastroenterology; Leroy V, Chevaliez S et. al.
Aug 1st, 2021 - Diagnosis of chronic hepatitis B virus (HBV) infection, initial staging of infection and monitoring of treated and untreated patients are mainly based on clinical, biological and imaging criteria allowing a complete non-invasive management for the...
https://doi.org/10.1016/j.clinre.2021.101772
Clinics and Research in Hepatology and Gastroenterology; Lemoinne S, Heurgue A et. al.
Aug 1st, 2021 - Autoimmune hepatitis (AIH) is a liver disease characterised by necrotico-inflammatory lesions of hepatocytes, the presence of specific autoantibodies and response to corticosteroid treatment. AIH must be considered in any patient with acute or chr...
Drugs 429 results see all →
Clinicaltrials.gov 1,515 results
https://clinicaltrials.gov/ct2/show/NCT04535037
May 19th, 2022 - The purpose of this study is to assess the safety and immunogenicity of GSK's combined diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b conjugate vaccine (DTPa-HBV-IPV/Hib) versus MCM ...
https://clinicaltrials.gov/ct2/show/NCT03439891
May 19th, 2022 - PRIMARY OBJECTIVES: I. Maximum tolerated dose (MTD) of sorafenib tosylate (sorafenib) in combination with standard dose nivolumab with Child Pugh A-B7 liver function. (Part 1: Escalation Cohort). II. Safety in patients with Child Pugh B liver func...
https://clinicaltrials.gov/ct2/show/NCT02446665
May 19th, 2022 - Primary sclerosing cholangitis (PSC) is a chronic liver disease that causes inflammation and obstruction of bile ducts. It can eventually lead to liver cirrhosis due to fibrosis, liver failure and liver cancer. The diagnosis of PSC is challenging ...
https://clinicaltrials.gov/ct2/show/NCT05382013
May 19th, 2022 - Artificial liver support system (ALSS) is an optimal therapy in patients with hepatitis b virus (HBV) related acute-on-chronic liver failure (ACLF). But a lot of patients encount thrombocytopenia (TCP) due to the mechanical damage of thrombocyte a...
https://clinicaltrials.gov/ct2/show/NCT05369507
May 18th, 2022 - Up to 150 individuals with current hepatitis C (HCV) will be recruited from mobile health clinics in rural South Carolina - sites will be selected based on HCV prevalence rates and lack of current HCV screening/treatment resources. NPs will provid...
News 4,033 results
https://www.medscape.com/viewarticle/974318
May 20th, 2022 - (Reuters) - A chain of events possibly triggered by unrecognized infection with the SARS-CoV-2 coronavirus could be causing the mysterious cases of severe hepatitis reported in hundreds of young children around the world, researchers suggest. Chil...
https://www.medscape.com/viewarticle/974307
May 19th, 2022 - The CDC says 180 children in the United States have been diagnosed with unexplained acute hepatitis, up from 109 cases 2 weeks ago. Most of those newly counted cases were "retrospective" patients, the CDC said in a Wednesday update on the outbreak...
https://www.mdedge.com/gihepnews/article/254678/hepatocellular-carcinoma/hcc-incidence-after-successful-daa-therapy
May 17th, 2022 - Key clinical point: Among patients with hepatitis C virus (HCV) who achieved a sustained virologic response (SVR) after direct-acting antiviral (DAA) therapy, those with cirrhosis showed an extremely high incidence of hepatocellular carcinoma (HCC.
https://www.medscape.com/viewarticle/973893
May 12th, 2022 - The CDC updated its recommendations for doctors and public health officials regarding the unusual outbreak of acute hepatitis among children. As of May 5, the CDC and state health departments are investigating 109 children with hepatitis of unknow...
https://www.medscape.com/viewarticle/973791
May 11th, 2022 - A complaint filed with the US Department of Justice (DOJ) alleges that Alabama's Medicaid program is illegally denying curative drug treatment for hepatitis C virus (HCV) infection to people with substance use disorder. The complaint was filed May...